› Home  › News
Last update: 20 Jun 2017
 
logo

News
Joining ERA-IB consortium MetaCat [January 2017]
Since January 2017 our department belongs to the MetaCat consortium - a metagenomic collection of novel and highly efficient biocatalysts for industrial biotechnology (→ read more)
New OBAC cluster funded within ERA-IB [November 2016]
Partners form Frankfurt, Ulm, La Coruna, Gent and Göttingen will work together within the joint project 'OBAC - Overcoming energetic barriers in acetogenic conversion of carbon dioxide'. (→ read more)
FLEXIZUCKER - new BMEL funded project [October 2016]
Process engineering, enzymatic and genomic characterization of a flexible biogas production with targeted use of sugar beets (→ read more)
Annual Genomics Workshop [July 2016]
The 4th 'International Workshop on Prokaryotic Genomics & Bioinformatics' took place from 19-22 July 2016. (→ read more)
CDiff project elongation until 2018 [July 2016]
A research co-operation of microbiologists from northern Germany analyses the hospital-aquired pathogen Clostridium difficile in order to develop new diagnostic tools and therapies. (→ read more)
arrowUp

News

› Joining ERA-IB consortium MetaCat [January 2017] (→ read more)
› New OBAC cluster funded within ERA-IB [November 2016] (→ read more)
› FLEXIZUCKER - new BMEL funded project [October 2016] (→ read more)
› Annual Genomics Workshop [July 2016] (→ read more)
› CDiff project elongation until 2018 [July 2016] (→ read more)
› ANTIRES - new joint project [June 2016] (→ read more)

CDiff project elongation until 2018 (July 2016)
A research co-operation of microbiologists from northern Germany analyses the hospital-aquired pathogen Clostridium difficile in order to develop new diagnostic tools and therapies.

CDiff: Epidemiology and systems biology of the bacterial pathogen Clostridium difficile

The bacterium Clostridium difficile is causing one of the most dangerous hospital acquired diseases. The so called C. difficile associated diarrhea (CDAD) has actually caught increasing attention as one of the most deadly, hospital-acquired diseases in Germany.

Despite its clinical relevance only little is known about the gene regulatory, protein and metabolic networks involved in the host associated life cycle of C. difficile. Within the CDiff project 13 interdisciplinary research groups from the 6 partner organizations of the NZMG (Norddeutsches Zentrum für Mikrobielle Genomforschung) will address and answer central open questions regarding the molecular basis of the C. difficile infection process. The systems biology approach on the model strain C. difficile 630 will help to elucidate and understand its metabolic pathways. Obtained data will constitute a solid basis for the development of novel prevention, diagnostic and therapeutic strategies.

The CDiff research project is funded by the 'Niedersächsisches Vorab' of the VolkswagenStiftung. Co-ordinator of the CDiff consortium is Prof. Dr. Dieter Jahn from the TU Braunschweig. Our department is going to address project II.1 "Genome analysis of C. difficile isolates derived from isolated populations".